Evidence map›Paper›PMID 40982460›Full record

SynthesisEuropean journal of endocrinology2025

Natural history of nonfunctioning pituitary microadenomas: a systematic review and individual participant data meta-analysis.

Victor B Boesen, Tue H Hansen, Mohammad Motawea, Maria Fleseriu, Elena V Varlamov, Ashley J Han, Syed A Imran, Vicki Munro, Mohammed Alenazi, Warrick J Inder and 11 more

Abstract readSystematic ReviewMeta-Analysis
In one paragraph

Synthesis in European journal of endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Victor B BoesenClinic for Pituitary Disorders, Department of Medicine, Zealand University Hospital, 4600 Køge, Denmark.ORCID 0000-0003-2792-6738
Tue H HansenClinic for Pituitary Disorders, Department of Medicine, Zealand University Hospital, 4600 Køge, Denmark.
Mohammad MotaweaClinic for Pituitary Disorders, Department of Medicine, Zealand University Hospital, 4600 Køge, Denmark.
Maria FleseriuPituitary Center, Department of Neurological Surgery and Department of Medicine, Oregon Health & Science University, Portland, OR 97239-3098, United States.ORCID 0000-0001-9284-6289
Elena V VarlamovPituitary Center, Department of Neurological Surgery and Department of Medicine, Oregon Health & Science University, Portland, OR 97239-3098, United States.
Ashley J HanPituitary Center, Department of Neurological Surgery and Department of Medicine, Oregon Health & Science University, Portland, OR 97239-3098, United States.ORCID 0000-0002-9303-9742
Syed A ImranDivision of Endocrinology, Department of Medicine, Dalhousie University, Halifax, NS, Canada B3H 2Y9.
Vicki MunroDivision of Endocrinology, Department of Medicine, Dalhousie University, Halifax, NS, Canada B3H 2Y9.
Mohammed AlenaziDivision of Endocrinology, Department of Medicine, Dalhousie University, Halifax, NS, Canada B3H 2Y9.
Warrick J InderDepartment of Diabetes and Endocrinology, Princess Alexandra Hospital, Brisbane, QLD 4102, Australia.
Nele LendersDepartment of Endocrinology, St Vincent's Hospital, Sydney, NSW 2010, Australia.ORCID 0000-0002-6738-0832
Roxana A DamilanoServicio de Endocrinología, Sanatorio Allende, X5000BFB Córdoba, Argentina.
Natalia L MonteserinDepartamento de Neuroendocrinología de la Sociedad de Endocrinología y Metabolismo de Córdoba (SEMCO), X5000HWJ Córdoba, Argentina.
Andrea G LaniaDepartment of Biomedical Sciences, Humanitas University, 20072 Pieve Emanuele, Milan, Italy.ORCID 0000-0002-5380-2141
Giulia CarosiEndocrinology Unit, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.
Giovanna MantovaniEndocrinology Unit, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.ORCID 0000-0002-9065-3886
Dawid HordejukRush Medical College, Rush University, Chicago, IL 60612, United States.
Le MinDivision of Endocrinology, Diabetes, and Hypertension, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, United States.ORCID 0000-0002-9126-1948
Ursula B KaiserDivision of Endocrinology, Diabetes, and Hypertension, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, United States.
Stefan D RikvoldDepartment of Endocrinology and Metabolism, Copenhagen University Hospital Rigshospitalet, 2200 Copenhagen, Denmark.
Jesper KroghClinic for Pituitary Disorders, Department of Medicine, Zealand University Hospital, 4600 Køge, Denmark.ORCID 0000-0003-4834-6724

Funding

Reproductive physiology of gonadotropin synthesisR37HD019938 · NICHD · BRIGHAM AND WOMEN'S HOSPITAL · PI Ursula B. Kaiser · 2019 to 2026
$4.3M
NICHD NIH HHS R37 HD019938
6 · The paper itself

Abstract

objectiveIncreased frequency of neuroimaging has led to enhanced identification of small nonfunctioning pituitary adenomas (NFPAs) leading, in many cases, to extensive follow-up. However, the value of ongoing monitoring of these incidental lesions remains unclear. The study aims to determine the need for surgical intervention and assess the risks of developing new endocrinopathies during follow-up in patients with conservatively treated micro-NFPAs.

designA systematic review and individual participant data (IPD) meta-analysis.

methodsWe conducted a bibliographical search of PubMed and EMBASE to identify relevant studies. Authors of eligible studies were invited to share IPD. Cohort studies including patients with conservatively treated micro-NFPAs with at least 1 follow-up magnetic resonance imaging were considered eligible. Fourteen studies met inclusion criteria. Six authors provided IPD (N = 647). Data were reanalyzed for verification. In cases of discrepancies the original authors were contacted for authentication.

resultsRisk estimates were reported as number of events per 100 person-years (PYs). Estimates were pooled using the 2-step approach. Overall probability of surgery was 0.2/100 PYs (95% CI: 0.0-0.4; I2 = 28%). Probability of surgery due to visual impairment was 0.1/100 PYs (95% CI: 0.0-0.2; I2 = 0%). Both were independent of baseline tumor size (≥6 or <6 mm), sex, or age (P values >.40). Risk of developing a new endocrinopathy was 1.0/100 PYs (95% CI: 0.4-1.6; I2 = 0%). Data for classical meta-analysis were available for 7 studies (N = 1089) and supported the IPD results.

conclusionsThese data suggest that routine follow-up of micro-NFPAs can be reduced significantly and that available guidelines should be revisited.

Indexed as

AdenomaPituitary NeoplasmsHumanshypopituitarismincidentalomanatural historypituitary adenomapituitary insufficiencytranssphenoidal surgeryvision loss

Identifiers

PMID40982460
PMCPMC13177312

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.